Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD  |  Issue: March 2013  |  March 1, 2013

Inasmuch as giant cells are seen in perhaps only one-half of biopsies from patients with “giant cell arteritis,” this descriptor is also inaccurate. “Temporal arteritis” is no better, in that arteritic involvement of extracranial arteries is increasingly recognized—indeed, subclinical inflammation of the aorta in GCA may be virtually invariable. A final nosologic vagary is the rubric of “large vessel vasculitis.” GCA is so categorized because it can involve of the aorta and great vessels, and because its histopathology shares similarities with other vasculitides of medium and large arteries, especially Takayasu arteritis. But it is actually the targeting of the tiny muscular arteries of the external carotid artery, of which the superficial temporal artery is a branch—about 0.8 mm in its normal diameter—that results in many of the characteristic symptoms of GCA.

PMR: Treatment Needs a Clinician, Not a Logician

However misleading the name, the clinical presentation of PMR is often immediately appreciated. Many clinicians will recognize a message from their front office to the effect that, “Mrs. A’s daughter called to ask if there is any way her mother’s appointment can be moved up—says that for the past two weeks she is so stiff she can hardly get out of bed in the morning.” Though the onset of the symptoms of PMR may be subacute, more often than not it is abrupt, occasionally startlingly so—patients have told me they went to bed feeling good, but awakened in the morning as though run over by the proverbial truck. The rapid onset of symptoms suggests the possibility of an exposure, particularly to an infectious agent, but the search for evidence of such a pathogen in PMR has been, to date, unrevealing. I have also been struck by what seems to be a curiously frequent reference to unusual physical activity just prior to the onset of symptoms of PMR—though I acknowledge the common penchant of patients to ascribe any musculoskeletal symptoms to prior trauma or exertion.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ferocious quality of the gel phenomenon in PMR is also distinctive. Though all systemic rheumatic diseases with synovitis are marked by gelling with inactivity, this symptom is particularly prominent in patients with PMR. Waking up at night with the mere act of rolling over in bed, needing help from a spouse with morning activities of daily living, especially with upper- and lower-extremity dressing, trouble transferring out of a car seat after a forty-five-minute ride—all testify to the potency of such gelling.

Page: 1 2 3 4 5 6 7 8 9 10 | Single Page
Share: 

Filed under:ConditionsSoft Tissue Pain Tagged with:Clinicalinflammationrheumatology

Related Articles

    Polymyalgia Rheumatica: New Tricks for an Old Disease

    January 29, 2024

    Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

    Permanent Vision Loss in Late Giant Cell Arteritis

    October 18, 2018

    Patients with polymyalgia rheumatica (PMR) or peripheral arthritis may require extra vigilance during treatment because of a suspected link to giant cell arteritis (GCA) and, potentially, permanent vision loss. “Development of giant cell arteritis after treating polymyalgia or peripheral arthritis: a retrospective case-control study,” a March 2018 study published in The Journal of Rheumatology, suggests…

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences